Nicotinic acid was administered orally to 33 patients with hypercholesterolemnia in doses varying from 1.5 to 6.0 Gm. per day for periods of 3 months to 11/2 years. Significant, sustained, and reproducible decreases in the concentration of cholesterol and total lipids in the plasma and of serum beta-lipoprotein cholesterol were observed in a majority of patients. This form of therapy appears to be effective, practical, and probably free fromt serious harmful effects.
IN 1955 Altschul and co-workers1 reported a decrease of serum cholesterol in normal and hypercholesterolemic individuals following the ingestion of 1 to 4 Gm. of nicotinic acid over a 24-hour period. Altschul has also described significant decreases of serum cholesterol in hypercholesterolemic rabbits when nicotinic acid was administered for 90 days, and in addition observed that in a majority of animals so treated expected atheroselerotic lesions were either absent or lessened in severity.2 3 These interesting observations led us, with Parsons,4 to investigate the long-term effects of large daily doses of nicotinic acid given orally to persons with hypercholesterolemia. The findings from this preliminary study were sufficiently encouraging to warrant continued investigation employing a greater number of patients over an even longer period. The purpose of this paper is to report our experience to date regarding the use of nicotinic acid as a means of lowering increased concentrations of blood lipids. and laboratory examination. Each was instructed to continue during the study whichever diet (unrestricted or low in fat) and medications he had employed prior to treatment. Therefore, in each case the only change in management was the addition of nicotinic acid.
METHODS
Initially, all patients were given 3 Gm. of nicotinic acid daily. This amount was usually taken on the schedule of 2 capsules (1 Gm.) t 3 times daily with meals. Whenever possible, changes in dosage were made only after a study period of at least 3 months in order for the effects of a given dose to become stabilized. After each patient had completed 6 This suggests that persons with higher initial concentrations of plasma cholesterol usually obtain a greater response to treatment with nicotinic acid than do those with lower pretreatment levels.
Of the 33 patients treated for at least 3 months, only 1 failed to achieve a decrease in the concentration of plasma lipids; in this instance the levels during treatment were slightly increased from those noted before treatment and during placebo administration. Thus far, 23 patients have maintained concentrations of plasma cholesterol that have averaged less than 260 mg. for at least 1 3-month period of treatment with nicotinic acid.
Effect of Treatment according to Sex, Age, and Diagnosis. An effort was made to determine whether various groups of patients showed significant differences in response to therapy. The women had only slightly higher pretreatment concentrations of plasma cholesterol than did the men, yet their response to treatment was nearly twice as great. Al * During the third 3-month period (6-9 mo.) a placebo was given.
the older group were women. Hence, the more favorable response to treatment exhibited by the older age group is probably related to the greater proportion of women in this group. The grouping of patients into those with familial hypercholesterolemia, those with disease of the coronary arteries, and those with arterial hypertension did not reveal any significant differences in response to treatment from that obtained by the entire group. As more information was obtained regarding relatives of the patients in this study, more of them could be classed as having familial hypereholesteroleniia. It seems likely that if sufficient data were available the hypercholesterolemia of nearly all our patients might be termed "'familial, ' it can be said that nonse of the patients with angina peetoris had any icrease ini their symptoms while being treated with nicotilic acid, and most of thenm considered that they were improved iii this regard. In contrast, it immust be poinited out that 1 patient sustained ani acute myocardial infarctionldurimig treatment. He has (onitiniued to take the drug, however, and his recovery has been uneventful. Two a(lditionial patients (lied suddenly and uiiexl)e(tedly while taking the placebo following 6 moniths of therapy with nicotinic acid. Necropsy revealed extensive coronary atherosclerosis as the cause of death in both patients. It seems unlikely that treatment with ii(cotiliic acid had aniy part in the deaths of these patients, but the possibility cannot be entirely excluded.
After 1 year of study all patients underwent a complete physical and laboratory examination including electrocardiograms and tests of hepatic and renal function in a further attempt to evaluate the efTects of treatment with nicotinic acid. No untoward results were noted.
.Msccla nisrn of Actioni. The mechanism by wvhichl nicotinic acid reduces the coneentration of blood lipids is not known. Altschul and co-workers have suggested that intracellular oxidation might be enhanced with a greater formation of oxycholesterols, and that this form may be more readily excreted thani cholesterol. 
